DK0406745T3 - Antibiotiske GE 2270 faktorer A1, A2, A3 og H - Google Patents
Antibiotiske GE 2270 faktorer A1, A2, A3 og HInfo
- Publication number
- DK0406745T3 DK0406745T3 DK90112547.6T DK90112547T DK0406745T3 DK 0406745 T3 DK0406745 T3 DK 0406745T3 DK 90112547 T DK90112547 T DK 90112547T DK 0406745 T3 DK0406745 T3 DK 0406745T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibiotic
- factors
- medicaments
- directed
- treatment
- Prior art date
Links
- 101000655610 Planobispora rosea Thiocillin GE2270 Proteins 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89112171 | 1989-07-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0406745T3 true DK0406745T3 (da) | 1995-02-27 |
Family
ID=8201585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90112547.6T DK0406745T3 (da) | 1989-07-04 | 1990-07-02 | Antibiotiske GE 2270 faktorer A1, A2, A3 og H |
Country Status (11)
Country | Link |
---|---|
US (2) | US5139778A (da) |
EP (1) | EP0406745B1 (da) |
JP (1) | JP2997510B2 (da) |
KR (1) | KR0165673B1 (da) |
AT (1) | ATE117724T1 (da) |
CA (1) | CA2020346C (da) |
DE (1) | DE69016284T2 (da) |
DK (1) | DK0406745T3 (da) |
ES (1) | ES2066914T3 (da) |
GR (1) | GR3015052T3 (da) |
IE (1) | IE67437B1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5139778A (en) * | 1989-07-04 | 1992-08-18 | Gruppo Lepetit Spa | Antibiotic ge 2270 factors a1, a2, a3 and h |
DK0451486T3 (da) * | 1990-03-08 | 1995-05-08 | Lepetit Spa | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T |
IL100572A (en) * | 1991-01-03 | 1997-01-10 | Lepetit Spa | Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them |
ATE163428T1 (de) * | 1991-08-30 | 1998-03-15 | Biosearch Italia Spa | Faktor c2a des antibiotikums ce 2270 |
US5882900A (en) * | 1992-09-10 | 1999-03-16 | Gruppo Lepetit S.P.A. | Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium |
CA2212437A1 (en) | 1995-02-07 | 1996-08-15 | Biosearch Italia S.P.A. | Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
JP2825667B2 (ja) * | 1995-02-07 | 1998-11-18 | バイオサーチ・イタリア・ソチエタ・ペル・アチオニ | Ge2270及びge2270−様抗生物質の塩基性プロリン−アミド誘導体 |
AU714958B2 (en) * | 1996-02-14 | 2000-01-13 | Vicuron Pharmaceuticals Inc. | Derivatives of antibiotic GE2270 factors C2a D2 and E |
JP4723857B2 (ja) * | 2002-06-17 | 2011-07-13 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | アクネの治療のためのge2270因子a3のアミド誘導体の使用 |
PE20121011A1 (es) * | 2006-05-31 | 2012-08-25 | Novartis Ag | AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu |
ATE500259T1 (de) * | 2006-12-20 | 2011-03-15 | Novartis Ag | Aminothiazolmakrocyclen, ihre verwendung als antibakterielle verbindungen und verfahren zu ihrer herstellung |
CA2708793C (en) | 2007-12-12 | 2016-06-21 | Novartis Ag | Aminothiazoles and their uses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR77567B (da) * | 1982-08-26 | 1984-09-24 | Lepetit Spa | |
GB8323382D0 (en) * | 1983-08-31 | 1983-10-05 | Lepetit Spa | Antibiotic sb 22484 |
GB8333624D0 (en) * | 1983-12-16 | 1984-01-25 | Lepetit Spa | Antibiotics l 17054 and l 17392 |
GB8821160D0 (en) * | 1988-09-09 | 1988-10-12 | Lepetit Spa | Antibiotic ge 2270 |
US5139778A (en) * | 1989-07-04 | 1992-08-18 | Gruppo Lepetit Spa | Antibiotic ge 2270 factors a1, a2, a3 and h |
-
1990
- 1990-07-02 US US07/547,647 patent/US5139778A/en not_active Expired - Lifetime
- 1990-07-02 AT AT90112547T patent/ATE117724T1/de not_active IP Right Cessation
- 1990-07-02 DE DE69016284T patent/DE69016284T2/de not_active Expired - Fee Related
- 1990-07-02 ES ES90112547T patent/ES2066914T3/es not_active Expired - Lifetime
- 1990-07-02 EP EP90112547A patent/EP0406745B1/en not_active Expired - Lifetime
- 1990-07-02 DK DK90112547.6T patent/DK0406745T3/da active
- 1990-07-03 JP JP2174621A patent/JP2997510B2/ja not_active Expired - Fee Related
- 1990-07-03 CA CA002020346A patent/CA2020346C/en not_active Expired - Fee Related
- 1990-07-03 KR KR1019900010007A patent/KR0165673B1/ko not_active IP Right Cessation
- 1990-07-03 IE IE240590A patent/IE67437B1/en not_active IP Right Cessation
-
1995
- 1995-02-15 GR GR950400291T patent/GR3015052T3/el unknown
- 1995-06-07 US US08/485,678 patent/US5547666A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69016284D1 (de) | 1995-03-09 |
CA2020346A1 (en) | 1991-01-05 |
KR910003107A (ko) | 1991-02-26 |
JPH0363289A (ja) | 1991-03-19 |
ES2066914T3 (es) | 1995-03-16 |
JP2997510B2 (ja) | 2000-01-11 |
CA2020346C (en) | 2000-10-10 |
EP0406745B1 (en) | 1995-01-25 |
US5139778A (en) | 1992-08-18 |
US5547666A (en) | 1996-08-20 |
ATE117724T1 (de) | 1995-02-15 |
IE902405A1 (en) | 1991-06-19 |
IE67437B1 (en) | 1996-04-03 |
EP0406745A1 (en) | 1991-01-09 |
DE69016284T2 (de) | 1995-05-24 |
KR0165673B1 (ko) | 1999-01-15 |
GR3015052T3 (en) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO902800D0 (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
DK617086A (da) | Antibiotikum a 40926 mannosyl-aglycon og additionssalte deraf samt laegemiddel indeholdende en saadan forbindelse | |
DE3682767D1 (de) | Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone. | |
DK0406745T3 (da) | Antibiotiske GE 2270 faktorer A1, A2, A3 og H | |
ES2111616T3 (es) | Compuestos de ciclohexapeptidil bisamina. | |
DK0451486T3 (da) | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T | |
ES2113391T3 (es) | Factor c2a de antibiotico ge 2270. | |
DK0487613T3 (da) | Megakarycytopiesk faktor | |
DK0675900T3 (da) | Antibiotika GE 37468 A, B og C | |
EP0359062A3 (en) | Antibiotic ge 2270 | |
AU6725387A (en) | Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms |